Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04755153 · ClinicalTrials.gov registry record · NA

Community Intervention to Reduce CardiovascuLar Disease in Chicago

A NA study of Hypertension, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
2,000
Enrollment target
3
Study locations

NCT04755153: Recruiting NA study of Hypertension, sponsored by Northwestern University.

NCT04755153 is a NA study of Hypertension that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 2,000 participants, below the 3,503-participant average among 470 other Hypertension trials with a reported enrollment target (43% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04755153, a NA study of Hypertension, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
3
Study locations

Study Summary

Hypertension affects 1 in every 3 adults in the US and contributes to 410,000 deaths annually. Hypertension and its associated complications disproportionately affect minority populations living in urban areas. In Chicago, health status indicators show worsening disparities between black and white residents, with the highest rates of hypertension, heart disease, and stroke clustering in the predominantly black South and West Sides. Kaiser Permanente demonstrated that a bundle of evidence-based interventions implemented within a large, integrated health system in Northern California significantly increased blood pressure control rates. However, it is unclear whether a health system centered intervention can be adapted to other settings, particularly under-resourced urban communities. Therefore, the overall goal is to support a community-centered design and adaptation of the Kaiser bundle. The investigative team will adapt the delivery model of the Kaiser bundle to be centered within churches within the South Side of Chicago, one of the most medically underserved communities in the United States. The proposed interventions are the same as in the Kaiser bundle (e.g., registry/audit and feedback, simplified treatment regimens, accurate Blood Pressure measurement) but implementation of the components of the bundle will be adapted for delivery in the community. The intervention will be carried out by local community health workers and ministry facilitators, with health clinics and hospitals in the community as support, all connected through a common data platform. Thus, the proposed project will identify the best strategies to support adoption, implementation with fidelity, and sustainability of the Kaiser bundle in the community setting. The proposed study will follow the Exploration, Preparation, Implementation and Sustainment (EPIS) process model and implementation is rigorously evaluated using a multimethod approach to the Reach, Effectiveness, Adoption, Implementati

Primary Outcome

The investigators will examine change in systolic blood pressure measured via automatic and manual devices as a result of participating in the intervention

Conditions Studied

Interventions

  • OTHER Practice Facilitation
  • OTHER Non-Practice Facilitation

Study Locations (3)

Illinois

  • Pastors4PCOR - Chicago
  • Access Community Health Network - Chicago
  • Advocate Aurora Health - Chicago

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-01-07
Est. Completion 2028-03-31
Phase NA
Northwestern University

1,209 total trials

What NCT04755153 shows while recruiting

NCT04755153 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,503-participant average among 470 other Hypertension trials with a reported enrollment target (43% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Practice Facilitation is the first listed.

NCT04755153 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04755153 about?

NCT04755153 is a clinical study titled "Community Intervention to Reduce CardiovascuLar Disease in Chicago". Hypertension affects 1 in every 3 adults in the US and contributes to 410,000 deaths annually. Hypertension and its associated complications disproportionately affect minority populations living in urban areas. In Chicago, health status indicators show worsening disparities between black and white r...

What is the current status of trial NCT04755153?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2025-01-07. Estimated completion is 2028-03-31.

What conditions does trial NCT04755153 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT04755153?

The interventions under investigation include: Practice Facilitation (OTHER), Non-Practice Facilitation (OTHER).

Who is sponsoring clinical trial NCT04755153?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04755153 being conducted?

This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04755153's enrollment target sits among peer trials

2,000 38th of 470 higher than 432 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04755153, the US trial registry maintained by the National Library of Medicine. NCT04755153 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.